Fount of Information

ACROBiosystems社 Weekly News from ACROBiosystems

この製品に関するご意見・ご照会・お問合せはこちら

Comprehensive_ADC_target_1.png

Join_us_now.jpg

We are hiring

 

Products Support Resources Insights About Us

  

Weekly News from ACROBiosystems

 

COVID-19.jpg 

ACROBiosystems is a life science company that provides reagents for the global vaccine industry. Having mobilized forces to develop SARS-CoV-2 recombinant antigens since the pandemic and accumulated mature technology and experiences with the virus and vaccines, we supply 200+ products and customized services that cover all the dominant strains of SARS-CoV-2 and support vaccine development of all technological platforms... 

>> Learn more

 

MABSOL.jpg

 

The interaction between biotin and avidin/streptavidin (SA) is powerful and specific, making it an excellent tool in CAR detection. ACROBiosystems has developed an exclusive collection of biotin-labeled CAR-T targets built upon the Avitag TM technology. These products have high bioactivity verified by FACS and are suitable for the evaluation of CAR expression...

>> Learn more

 

GMP.jpg 

The successful translation of your cell therapy products hinges upon material-selection decisions that impact manufacturing. Raw materials chosen in the early stages need to conform to all regulatory criteria when entering clinical trials and later stages. At ACROBiosystems, we ensure that our GMP products follow regulatory standards from internationally recognized bodies including ISO, US, and European Pharmacopeias...

>> Learn more

 

FLAG.jpg

FLAG, which stands for Full Length Active Gallery, refers to ACROBiosystems's multi-pass transmembrane proteins technology platforms. ACROBiosystems has specially set up FLAG to develop a gallery of full-length multi-pass transmembrane proteins with native conformation to meet the needs of different applications in the process of drug and therapy development... 

>> Download the brochure

Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。